Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results48

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results30

Views

Views
October 20243
November 20246
December 20241
January 20252
February 20253
March 202512
April 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Singapore11
United Kingdom2
Spain1
 

Top cities views

Views
Santa Clara4
Council Bluffs1